SEARCH

SEARCH BY CITATION

Bibliography

  • 1
    Bazzoli F & Pozzato P. Therapy of H. pylori infection. J Physiol Pharmacol 1997; 48(Suppl. 4): S39S46.
  • 2
    Pipkin GA, Williamson R & Wood JR. Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori. Aliment Pharmacol Ther 1998; 12: 82337.DOI: 10.1046/j.1365-2036.1998.00405.x
  • 3
    Graham DY. Antibiotic resistance in Helicobacter pylori: implications for therapy. Gastroenterology 1998; 115: 12727.
  • 4
    Mégraud F. Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori. Gastroenterology 1998; 115: 127882.
  • 5
    Mégraud F. Antibiotic resistance in Helicobacter pylori infection. Br Med Bull 1998; 54: 20716.
  • 6
    Debets-Ossenkopp YJ, Herscheid AJ, Pot RG, Kuipers EJ, Kusters JG & Vandenbroucke-Grauls CM. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands. J Antimicrob Chemother 1999; 43: 5115.DOI: 10.1093/jac/43.4.511
  • 7
    Adamek RJ, Suerbaum S, Pfaffenbach B & Opferkuch W. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin—influence on treatment outcome. Am J Gastroenterol 1998; 93: 3869.
  • 8
    Realdi G, Dore MP & Piana A, et al. Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies. Helicobacter 1999; 4: 10612.DOI: 10.1046/j.1523-5378.1999.99002.x
  • 9
    Pilotto A, Leandro G & Franceschi M, et al. The effect of antibiotic resistance on the outcome of three 1-week triple therapies against Helicobacter pylori. Aliment Pharmacol Ther 1999; 13: 66773.DOI: 10.1046/j.1365-2036.1999.00508.x
  • 10
    Dore MP, Leandro G, Realdi G, Sepulveda AR & Graham DY. Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach. Dig Dis Sci 2000; 45: 6876.
  • 11
    Mégraud F, Bonnet F, Garnier M & Lamouliatte H. Characterization of ‘Campylobacter pyloridis’ by culture, enzymatic profile, and protein content. J Clin Microbiol 1985; 22: 100710.
  • 12
    National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Test for Bacteria That Grow Aerobically, 4th edn. Approved Standard M7-A3. Villanova, Pa: NCCLS, 1997.
  • 13
    Lee J & O’Morain C. Consensus or confusion: a review of existing national guidelines on Helicobacter pylori-related disease. Eur J Gastroenterol Hepatol 1997; 9: 52731.
  • 14
    The European Helicobacter pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997; 41: 813.
  • 15
    Hardy DY, Swanson RN, Rode RA, Marsh K, Shipkowitz NL & Clement JJ. Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans. Antimicrob Agents Chemother 1990; 34: 140713.
  • 16
    Pendland SL, Piscitelli SC, Schreckenberger PC & Danziger LH. In vitro activities of metronidazole and its hydroxy metabolite against Bacteroides spp. Antimicrob Agents Chemother 1994; 38: 210610.
  • 17
    Bergan T. Antibacterial activity and pharmacokinetics of nitroimidazoles. A review. Scand J Infect Dis Suppl 1985; 46: 6471.
  • 18
    De Boer WA & Tytgat GNJ. Regular review: treatment of Helicobacter pylori infection. Br Med J 2000; 320: 314.
  • 19
    Pajares-Garcia JM. Diagnosis of Helicobacter pylori: invasive methods. Ital J Gastroenterol Hepatol 1998; 30(Suppl. 3): S3203.
  • 20
    Breuer T & Graham DY. Costs of diagnosis and treatment of Helicobacter pylori infection: when does choosing the treatment regimen based on susceptibility testing become cost effective? Am J Gastroenterol 1999; 94: 7259.
    Direct Link:
  • 21
    Perri F, Festa V, Clemente R, Quitadamo M & Andriulli A. Rifabutin-based ‘rescue therapy’ for Helicobacter pylori infected patients after failure of standard regimens. Aliment Pharmacol Ther 2000; 14: 3116.DOI: 10.1046/j.1365-2036.2000.00719.x
  • 22
    Ferguson DaJr, Jiang C, Chi DS, Laffan JJ, Li C & Thomas E. Evaluation of two string tests for obtaining gastric juice for culture, nested-PCR detection, and combined single- and double-stranded conformational polymorphism discrimination of Helicobacter pylori. Dig Dis Sci 1999; 44: 205662.